Accelerate Diagnostics Net Tangible Assets

Accelerate Diagnostics (AXDX) currently reports a net tangible assets of $-56M as of December 2024. That compares with $-20M in the prior-year period — down 181.8% year over year. Use the charts on this page to explore Accelerate Diagnostics's net tangible assets history and peer comparisons.

Accelerate Diagnostics's net tangible assets decreased from $-20M to $-56M — a 181.8% year-over-year decrease (period ending December 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Accelerate Diagnostics reported $-56M in net tangible assets as of December 2024. That compares with $-20M in the prior-year period — down 181.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $-56M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Accelerate Diagnostics, and consider following AXDX for alerts when major investors trade the stock.

Accelerate Diagnostics is classified in the Healthcare sector. On net tangible assets, it currently shows $-56M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AXDX with unrelated industries.